CaPPE [11] is a collaboration between the National Cancer Registry, the Department of Pharmacology & Therapeutics, Trinity College Dublin and the National Centre for Pharmacoeconomics. The focus of the collaboration is research in the areas of cancer pharmacoepidemiology and pharmacoeconomics. Pharmacoepidemiology research involves the investigation – at the population-level – of the effects of medications on cancer. Pharmacoeconomics assesses the economic impact of medications and drugs in cancer.
Cancer pharmacoepidemiology research in Ireland is made possible by the bringing together - by the National Cancer Registry - of individual records for cancer and prescribed medications, held by the Primary Care Reimbursement Service. The collaboration has been funded by several project and programme grants from the Health Research Board and PhD studentships from the Irish Cancer Society. Current projects include:
Links
[1] https://www.ncri.ie/research-status/dissemination
[2] https://www.ncri.ie/cancers/breast
[3] https://www.ncri.ie/cancers/colorectal
[4] https://www.ncri.ie/cancers/lung
[5] https://www.ncri.ie/cancers/ovary
[6] https://www.ncri.ie/cancers/prostate
[7] https://www.ncri.ie/research-theme/health-services-research
[8] https://www.ncri.ie/research-theme/aetiological-research
[9] https://www.ncri.ie/research-workstream/pharmaco-epidemiology
[10] https://www.ncri.ie/https
[11] http://medicine.tcd.ie/pharmacology_therapeutics/research/research-projects/pharmacoepidemiology.php
[12] https://www.ncri.ie/news/article/how-do-ovarian-cancer-patients-and-without-medical-cards-differ
[13] https://www.ncri.ie/news/article/national-cancer-research-institute-ncri-cancer-conference-2015-0
[14] https://www.ncri.ie/news/article/does-taking-aspirin-reduce-risk-breast-cancer-spreading
[15] https://www.ncri.ie/news/article/national-cancer-registry-supports-daffodil-day-2014
[16] https://www.ncri.ie/news/article/photos-ice-awards-conference-2014
[17] https://www.ncri.ie/news/article/use-anti-diabetic-drug-metformin-may-be-associated-lower-chances-being-diagnosed
[18] https://www.ncri.ie/news/article/pre-diagnostic-use-aspirin-may-be-associated-lower-mortality-men-prostate-cancer
[19] https://www.ncri.ie/news/article/cancer-pharmacoepidemiology-symposium-presentations-now-available
[20] https://www.ncri.ie/research/scientific-papers/can-demographic-clinical-and-treatment-related-factors-available-0
[21] https://www.ncri.ie/research/scientific-papers/de-novo-post-diagnosis-aspirin-use-and-mortality-women-stage-i-iii-breast
[22] https://www.ncri.ie/research/scientific-papers/recent-prediagnostic-aspirin-use-lymph-node-involvement-and-5-year
[23] https://www.ncri.ie/research/scientific-papers/cohort-study-investigating-aspirin-use-and-survival-men-prostate-cancer
[24] https://www.ncri.ie/research/scientific-papers/metformin-exposure-and-disseminated-disease-patients-colorectal-cancer
[25] https://www.ncri.ie/research/scientific-papers/cohort-study-digoxin-exposure-and-mortality-men-prostate-cancer
[26] https://www.ncri.ie/research/scientific-papers/cohort-study-metformin-exposure-and-survival-patients-stage-i-iii
[27] https://www.ncri.ie/research/scientific-papers/beta-adrenergic-blocking-drugs-breast-cancer-perspective-review
[28] https://www.ncri.ie/research/scientific-papers/beta-blockers-and-breast-cancer-mortality-population-based-study
[29] https://www.ncri.ie/research/scientific-papers/nested-case-control-study-adjuvant-hormonal-therapy-persistence-and
[30] https://www.ncri.ie/research/presentations/caution-time-event-models-where-pre-event-state-modifies-time-varying
[31] https://www.ncri.ie/research/presentations/bias-prescription-data-irish-ovarian-cancer-population
[32] https://www.ncri.ie/email/node/758/field_contact_email